Copy
Twitter
LinkedIn
May 2021

BioCurate and Monash University launch oncology startup company, Pio Therapeutics

BioCurate and Monash University announced the launch of Pio Therapeutics (Pio Tx), a new company that will focus on developing novel, innovative and targeted medicines to improve outcomes for cancer patients. 

Continue reading »

 

New genomic tool advances melanoma risk prediction in older Australians

School researchers have developed a new genomic risk score for melanoma (skin cancer), and shown it to be of value when used to predict melanoma risk in older people. Their findings were published in the Journal of the National Cancer Institute recently.

Continue reading »

Australian Breast Device Registry helps with Victorian patient safety

The Australian Breast Device Registry (ABDR) will be at the forefront to help the Victorian public become better informed about a rare form of cancer linked to breast implants. The Monash University-led ABDR is operating a dedicated consumer help line for Victorians with breast implants as part of broader public awareness campaign led by Safer Care Victoria.

Continue reading » 

Paediatric brain tumour immunotherapy research awarded Ideas Grant funding

Congratulations to Dr Pouya Faridi who was recently awarded an Ideas Grant in the 2020 round of the Priority-driven Collaborative Cancer Research Scheme. The Scheme brings together government and other funders to fund cancer research in Australia. It is managed by Cancer Australia, collaborating with the NHMRC, which assesses applications and endorses grants in recognition of their scientific merit.

Continue reading » 

Monash study may help boost peptide design

Peptides – short strings of amino acids – play a vital role in health and industry with a huge range of medical uses including in antibiotics, anti-inflammatory and anti-cancer drugs. They are also used in the cosmetics industry and for enhancing athletic performance.

Continue reading » 

A journey through brain cancer treatment

When a person presents to the hospital with symptoms that could be caused by a brain tumour, the first step would be to see the neuroradiology department. The scans taken would then need to be examined by a specialist neuroradiologist to provide their diagnosis of the presumed brain tumour.

Continue reading » 

“On the road towards a cure” – fundraiser for brain cancer research at The Alfred

Last January, after having a seizure Anthony was taken to Frankston hospital for a computerised tomography (CT) scan. The doctors saw what they suspected to be a tumour, and he was sent to The Alfred for a magnetic resonance imaging (MRI) scan.

Continue reading » 

A Cabrini clinical trial has changed the future for one lucky grandmother

It’s hard to imagine what life has in store for you, but it’s even harder after being diagnosed with a terminal illness. Unfortunately, this has been the reality for 69-year-old Loretta who was diagnosed with ovarian cancer in April 2017. 

Continue reading » 

Associate Professor Charles Pilgrim

Learn about a day in the life of Associate Professor Charles Pilgrim, adjunct Associate Professor in the Department of Surgery, Central Clinical School, Monash University, adjunct Associate Professor School of Public Health and Preventative Medicine (Monash University), Lieutenant Colonel, Trauma Surgeon with the Australian Defence Force. 

Continue reading » 

Oral Cancer

Oral cancer is on the rise in Victoria, but early detection can save lives. Explore the new Oral Cancer Learning Hub from Dental Health Services Victoria (DHSV) to enhance your knowledge and skills.

Monash Partners Consumer and Community Involvement

Listen to recordings of recent MP lunchtime webinars including:
Setting up consumer advisory committees for health services
Navigating power imbalances in consumer and community involvement

For more information, visit the Monash Partners website, contact the Monash Partners CCI team at cci@monashpartners.org.au or complete the CCI advice request form

The Australian National Audit Office (ANAO) is seeking input to assess whether the Department of Health is effectively managing the Medical Research Future Fund (MRFF).  To have your say, provide a written submission via the ANAO website . The consultation is open until 31 May 2021

Find out more »

MRFF 2021 Rare Cancers Rare Diseases Unmet Need General – Grant Opportunity

Applications via NHMRC

Closing Dates
Stream 2: 5.00pm Wednesday 7 July 2021
Streams 1, 3, 5, 6 and 7: 5.00pm Wednesday 18 August 2021 

Please note there are 7 specific streams in this round of RCRDUN and min data dates vary across streams

Min Data
Stream 2: 5.00pm on Wednesday 23 June 2021
Streams 1, 3, 4, 5, 6 and 7: 5.00pm on Wednesday 4 August 2021

Grants are a max of $5M, $10M or $15M depending on Stream. Funding over 3 years.
See guidelines for details. A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a Chief Investigator on a maximum of one application per Stream).

Find out more »

MRFF – 2021 COVID 19 Health Impacts and Vaccination Schedules Grant Opportunity

Applications via NHMRC

Closing Date: 5.00pm Wednesday 18 August 2021 

Min Data 5.00pm Wednesday 4 August 2021 
Grants are a max of $15M. Funding over 3 years. See guidelines for details

Stream 1: study individuals that have tested positive for COVID-19 to improve understanding of the long term health impacts of COVID-19
Stream 2: conduct clinical trials to generate evidence on how individuals or populations with immunocompromising conditions respond to COVID-19 vaccination, to inform vaccine schedules
Stream 3: conduct clinical trials to generate knowledge on the efficacy of vaccine schedules that combine different COVID-19 vaccines.
A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity.

Find out more »

Cancer trials management scheme – competitive grants NOW OPEN

Together, Cancer Council Victoria and the Victorian Cancer Agency will fund three $500K projects for a maximum of 3 years.

This funding will be offered to projects that address:
  • an unmet need and
  • build capacity to conduct and recruit to cancer clinical trials in supportive care and/or survivorship. 

For further information contact Dorani Lacey at Cancer Council Victoria on 03 9514 6319 or email grants@cancervic.org.au. Applications will close on Thursday 15 July 2021.

Find out more »
MIME Seed Funding now open: Practical solutions for frontline clinical problems

This is an opportunity for clinicians to realise unmet clinical needs and work in partnership with researchers to discover new medical technologies.

Applications may request up to $50,000 per project for medtech collaborative projects involving a Faculty of Medicine, Nursing, Health and Science clinician researcher and a Monash engineering, IT and/or Arts and Design researcher.

Application forms will be made available on the MIME website following the Virtual Affinity Meeting on Friday 18 June, 1-3pm.

Questions? Contact Andrew Carey, MIME Program Manager on phone 0408 700 029 or email andrew.carey@monash.edu

Find out more »  |  Register your interest »
2021 GSK Award for Research Excellence: Nominations Now Open

The GSK Award for Research Excellence (ARE) is one of the most prestigious and longstanding awards available to the Australian medical research community. Since 1980, the annual GSK ARE has been awarded to individuals or two-person teams with very significant existing track records who are well placed to further their contributions in the near future. A financial grant of $80,000 to the winner(s)’ institution supports this goal.

To nominate someone, complete the 2021 ARE Nomination Form. For further information about the nominations process view the Terms of Reference. Please direct queries regarding the award to are.arenominations@gsk.com

Nominations close at midnight on Friday 30 July 2021.The award will be presented at the Research Australia Awards Night, Thursday 9 December 2021 in Sydney.

Sex disparities matter in cancer development and therapy: Dr Sue Haupt
When: Monday 7 June 
Time: 1pm to 2pm
Where: Online
More information and registration

5th Victorian Cancer Survivorship Research Forum 2021
When: Thursday 10 June 
Time: 2pm to 3.30pm
Where: Online
More information and registration

Breast Cancer 2021 Victorian Tumour Summit (VTS)
When: Friday 25 June
Time: 9am to 1pm
Where: RACV City Club, Melbourne
Contact: Janine Scott on 94963322 or janine.scott@austin.org.au
More information and registration

 
The consumer perspective – what works and doesn’t work in consumer and community involvement
When: Thursday 10 June
Time: 1pm to 2pm
Where: Online
Register now

Cancer Nurses Society Australia Annual Congress- Nurses: A Voice to Lead
When: Friday 18 June
Time: All day event
Where: Melbourne Convention and Exhibition Centre
More information and registration

Collaborate Innovate
When: 9 - 11 August
Where: Canberra
Expressions of interest

COSA 48th Annual Scientific Meeting: Cancer care and research
When: 16-18 November
Where: Melbourne
More information

 

Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer  Read article »

Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016  Read article »

Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis  Read article »

Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis  Read article »

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy  Read article »

Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study  Read article »

Palliative care needs and utilisation of different specialist services in the last days of life for people with lung cancer  Read article »

Australian Cancer Plan

Cancer Australia is to develop the first Australian Cancer Plan to provide an overarching national approach to cancer control that meets the needs of all Australians now and in the future.

Continue reading »
‘Devastated and sad’ after 36 years of research — early detection of ovarian cancer doesn’t save lives

My colleagues’ and my efforts to develop a screening test for the early detection of ovarian cancer capable of saving lives arrived at a sad moment last week. The final trial results of the research I’ve focused on for 36 years, published in The Lancet, found early ovarian cancer detection doesn’t save lives.

Continue reading »
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
Twitter
LinkedIn
If you would like to contribute to the MPCCC e-Newsletter email info@monashpartnersccc.org
Copyright © 2021 MPCCC, All rights reserved.